• Virtual (VR) and augmented reality (AR) technologies have grown in popularity as they can immerse users in novel situations and environments by simulating the necessary stimuli.
  • However, when using VR or AR technologies such as head-worn displays, users frequently report symptoms of nausea, disorientation, and sleepiness.
  • This is more commonly referred to as cybersickness, a form of motion sickness that has been caused by the use of technology.

Abu Dhabi: Associate Professor of Psychology and Director of the Neuroimaging Center at NYU Abu Dhabi Bas Rokers and a team of researchers have evaluated the state of research on cybersickness and formulated a research and development agenda to eliminate cybersickness, allowing  for broader adoption of immersive technologies.

In the paper titled Identifying Causes of and Solutions for Cybersickness in Immersive Technology: Reformulation of a Research and Development Agenda, published in the International Journal of Human–Computer Interaction, Rokers and his team discuss the process of creating a research and development agenda based on participant feedback from a workshop titled Cybersickness: Causes and Solutions and analysis of related research. The new agenda recommends prioritizing the creation of powerful, lightweight, and untethered head-worn displays, reducing visual latencies, standardizing symptom and aftereffect measurement, developing improved countermeasures, and improving the understanding of the magnitude of the problem and its implications for job performance.

The results of this study have identified a clear path towards finding a solution for cybersickness and allowing for the widespread use of immersive technologies. In addition to its use in entertainment and gaming, VR and AR have significant applications in the domains of education, manufacturing, training, health care, retail, and tourism. For example, it can enable educators to introduce students to distant locations and immerse themselves in a way that textbooks cannot. It can also allow healthcare workers to reach patients in remote and underserved areas, where they can provide diagnostics, surgical planning and image-guided treatment.

“As there are possible applications across many industries, understanding how to identify and evaluate the opportunities for mass adoption and the collaborative use of AR and VR is critical,” said Rokers. “Achieving the goal of resolving cybersickness will allow the world to embrace the potential of immersive technology to enhance training, performance, and recreation.”

-Ends-

About NYU Abu Dhabi

NYU Abu Dhabi is the first comprehensive liberal arts and science campus in the Middle East to be operated abroad by a major American research university. NYU Abu Dhabi has integrated a highly-selective liberal arts, engineering and science curriculum with a world center for advanced research and scholarship enabling its students to succeed in an increasingly interdependent world and advance cooperation and progress on humanity’s shared challenges. NYU Abu Dhabi’s high-achieving students have come from more than 115 nations and speak over 115 languages. Together, NYU's campuses in New York, Abu Dhabi, and Shanghai form the backbone of a unique global university, giving faculty and students opportunities to experience varied learning environments and immersion in other cultures at one or more of the numerous study-abroad sites NYU maintains on six continents.

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.